Eva Medvedova
- Hematology top 2%
- Molecular Biology
- Oncology top 10%
- Genetics top 10%
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Rebecca SilbermannParameswaran HariKelly GodbySaurabh ChhabraNatalie S. CallanderLuciano J. CostaRobert F. CornellPamela Hardwick
- Topics
- Multiple Myeloma Research and Treatments (37 papers)Protein Degradation and Inhibitors (14 papers)Chronic Lymphocytic Leukemia Research (8 papers)
- Cited by
- HematologyOncologyGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Eva Medvedova
43 papers receiving 722 citations
Peers
Comparison fields: 5 of 45
- Hematology 567
- Molecular Biology 536
- Oncology 373
- Genetics 120
- Radiology, Nuclear Medicine and Imaging 68
Countries citing papers authored by Eva Medvedova
This map shows the geographic impact of Eva Medvedova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Medvedova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Medvedova more than expected).
Fields of papers citing papers by Eva Medvedova
This network shows the impact of papers produced by Eva Medvedova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Medvedova. The network helps show where Eva Medvedova may publish in the future.
Co-authorship network of co-authors of Eva Medvedova
This figure shows the co-authorship network connecting the top 25 collaborators of Eva Medvedova. A scholar is included among the top collaborators of Eva Medvedova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Medvedova. Eva Medvedova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 71 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 0 | |
| 10 | 146 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 5 | |
| 14 | 93 | |
| 15 | 26 | |
| 16 | 24 | |
| 17 | 9 | |
| 18 | 1 | |
| 19 | 28 | |
| 20 | 29 |
About Eva Medvedova
Eva Medvedova is a scholar working on Hematology, Genetics and Oncology, having authored 47 papers that have together received 737 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (37 papers), Protein Degradation and Inhibitors (14 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Hematology (567 citations), Oncology (373 citations) and Genetics (120 citations). Eva Medvedova has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Rebecca Silbermann, Parameswaran Hari, Kelly Godby, Saurabh Chhabra, Natalie S. Callander, Luciano J. Costa, Robert F. Cornell, Pamela Hardwick, Aric C. Hall and James Omel. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.